Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
scPharmaceuticals
(NASDAQ:SCPH)
Intraday
$4.35
0
[0.00%]
15 minutes delayed
Get Report
Watch
Perks
Buy
Compare Brokers
$4.35
0
[0.00%]
Last update: 4:20PM
Get Real Time Here
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for scPharmaceuticals Stock (NASDAQ:SCPH)
scPharmaceuticals Stock (NASDAQ: SCPH)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, April 24, 2024
scPharmaceuticals Enrolls First Participant In Pivotal Pharmacokinetic Study Of FUROSCIX Auto-Injector Injection
Benzinga Newsdesk
-
2 days ago
Friday, April 05, 2024
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
-
Apr 5, 2024, 8:09AM
Thursday, March 14, 2024
HC Wainwright & Co. Reiterates Buy on scPharmaceuticals, Maintains $18 Price Target
Benzinga Newsdesk
-
Mar 14, 2024, 7:23AM
Wednesday, March 13, 2024
Recap: scPharmaceuticals Q4 Earnings
Benzinga Insights
-
Mar 13, 2024, 4:10PM
scPharmaceuticals Q4 2023 GAAP EPS $(0.35) Beats $(0.42) Estimate, Sales $6.096M Beat $5.525M Estimate
Benzinga Newsdesk
-
Mar 13, 2024, 4:07PM
Earnings Scheduled For March 13, 2024
Benzinga Insights
-
Mar 13, 2024, 6:15AM
Tuesday, March 12, 2024
A Preview Of scPharmaceuticals's Earnings
Benzinga Insights
-
Mar 12, 2024, 11:01AM
Monday, January 22, 2024
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
-
Jan 22, 2024, 8:05AM
Thursday, January 04, 2024
ScPharmaceuticals Sees Prelim. FY23 FUROSCIX Revenue $13.4M-$13.6M Vs $12.82M Est.
Benzinga Newsdesk
-
Jan 4, 2024, 4:09PM
ScPharmaceuticals Sees Prelim. Q4 FUROSCIX Revenue $5.9M-$6.1M Vs $5.32M Est.
Benzinga Newsdesk
-
Jan 4, 2024, 4:08PM
Wednesday, November 08, 2023
Recap: scPharmaceuticals Q3 Earnings
Benzinga Insights
-
Nov 8, 2023, 4:25PM
scPharmaceuticals Q3 EPS $(0.41) Misses $(0.36) Estimate, Sales $3.80M Beat $3.39M Estimate
Benzinga Newsdesk
-
Nov 8, 2023, 4:20PM
Earnings Scheduled For November 8, 2023
Benzinga Insights
-
Nov 8, 2023, 4:21AM
Tuesday, November 07, 2023
Earnings Preview: scPharmaceuticals
Benzinga Insights
-
Nov 7, 2023, 11:01AM
Tuesday, September 19, 2023
scPharmaceuticals Announces Feedback From Two FDA Meetings Related To The Development Of An 80mg/1mL Auto-Injector
Benzinga Newsdesk
-
Sep 19, 2023, 8:13AM
Thursday, September 07, 2023
Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2023
Benzinga Insights
-
Sep 7, 2023, 11:00AM
Craig-Hallum Initiates Coverage On scPharmaceuticals with Buy Rating, Announces Price Target of $20
Benzinga Newsdesk
-
Sep 7, 2023, 8:48AM
Friday, August 11, 2023
HC Wainwright & Co. Reiterates Buy on scPharmaceuticals, Maintains $18 Price Target
Benzinga Newsdesk
-
Aug 11, 2023, 8:34AM
Thursday, August 10, 2023
scPharmaceuticals Q2 EPS $(0.36) Beats $(0.37) Estimate
Benzinga Newsdesk
-
Aug 10, 2023, 4:01PM
Earnings Scheduled For August 10, 2023
Benzinga Insights
-
Aug 10, 2023, 6:59AM
Wednesday, August 09, 2023
Earnings Outlook For scPharmaceuticals
Benzinga Insights
-
Aug 9, 2023, 11:01AM
Wednesday, August 02, 2023
HC Wainwright & Co. Reiterates Buy on scPharmaceuticals, Maintains $18 Price Target
Benzinga Newsdesk
-
Aug 2, 2023, 6:09AM
Tuesday, August 01, 2023
scPharmaceuticals Announces Type C Meeting Feedback From FDA On Potential Heart Failure Class IV Indication Expansion
Happy Mohamed
-
Aug 1, 2023, 8:13AM
Wednesday, July 19, 2023
The Latest Analyst Ratings for scPharmaceuticals
Benzinga Insights
-
Jul 19, 2023, 9:00AM
HC Wainwright & Co. Reiterates Buy on scPharmaceuticals, Maintains $18 Price Target
Benzinga Newsdesk
-
Jul 19, 2023, 6:04AM
Thursday, June 29, 2023
Short Interest Sector Focus: Healthcare Sector
Christopher Sappo
-
Jun 29, 2023, 12:56PM
Wednesday, June 28, 2023
Short Interest Sector Focus: Healthcare Sector
Christopher Sappo
-
Jun 28, 2023, 10:24AM
Friday, June 23, 2023
scPharmaceuticals Inc. Announces Addition to Russell 2000 and Russell 3000 Indexes
Benzinga Newsdesk
-
Jun 23, 2023, 8:05AM
Thursday, June 08, 2023
Analyst Ratings for scPharmaceuticals
Benzinga Insights
-
Jun 8, 2023, 9:01AM
HC Wainwright & Co. Reiterates Buy on scPharmaceuticals, Maintains $18 Price Target
Benzinga Newsdesk
-
Jun 8, 2023, 6:17AM
Thursday, May 11, 2023
Maxim Group Maintains Buy on scPharmaceuticals, Raises Price Target to $20
Benzinga Newsdesk
-
May 11, 2023, 10:32AM
HC Wainwright & Co. Reiterates Buy on scPharmaceuticals, Maintains $18 Price Target
Benzinga Newsdesk
-
May 11, 2023, 6:30AM
Wednesday, May 10, 2023
scPharmaceuticals Q1 EPS $(0.30) Beats $(0.36) Estimate
Happy Mohamed
-
May 10, 2023, 4:05PM
Earnings Scheduled For May 10, 2023
Benzinga Insights
-
May 10, 2023, 9:12AM
Tuesday, May 09, 2023
Earnings Outlook For scPharmaceuticals
Benzinga Insights
-
May 9, 2023, 11:03AM
Thursday, April 13, 2023
scPharmaceuticals Option Alert: Apr 21 $10 Calls at the Ask: 1581 @ $1.0 vs 1716 OI; Earnings 5/15 Before Open [est] Ref=$10.8
Charles Gross
-
Apr 13, 2023, 11:34AM
Thursday, March 23, 2023
Dow Up 150 Points; Gold Jumps Over 2%
Lisa Levin
-
Mar 23, 2023, 2:32PM
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
-
Mar 23, 2023, 1:31PM
Why Block Shares Are Trading Lower By Over 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Lisa Levin
-
Mar 23, 2023, 1:11PM
Nasdaq Surges Over 2%; Accenture To Reduce 19,000 Jobs
Lisa Levin
-
Mar 23, 2023, 12:13PM
KB Home, Accenture, Netflix And Other Big Stocks Moving Higher On Thursday
Lisa Levin
-
Mar 23, 2023, 10:39AM
scPharmaceuticals shares are trading higher after the company reported better-than-expected Q4 EPS results.
Michael Horton
-
Mar 23, 2023, 10:18AM
HC Wainwright & Co. Reiterates Buy on scPharmaceuticals, Maintains $18 Price Target
Benzinga Newsdesk
-
Mar 23, 2023, 6:17AM
Wednesday, March 22, 2023
scPharmaceuticals Q4 EPS $(0.27) Beats $(0.39) Estimate
Happy Mohamed
-
Mar 22, 2023, 4:34PM
Earnings Scheduled For March 22, 2023
Benzinga Insights
-
Mar 22, 2023, 7:58AM
Tuesday, March 21, 2023
Earnings Preview For scPharmaceuticals
Benzinga Insights
-
Mar 21, 2023, 12:00PM
Friday, March 10, 2023
ScPharmaceuticals Says Has Two Deposit Accounts At Silicon Valley Bank, Each With Balance Of Equal To Or Less Than $250,000 As Of March 10
Benzinga Newsdesk
-
Mar 10, 2023, 12:31PM
Monday, February 27, 2023
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
-
Feb 27, 2023, 4:31PM
Tuesday, February 21, 2023
scPharmaceuticals Announces Launch And Commercial Availability Of FUROSCIX
Happy Mohamed
-
Feb 21, 2023, 8:11AM
Friday, February 17, 2023
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
-
Feb 17, 2023, 4:31PM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch